Synthesis, cytotoxic activity and docking studies of new 4-aza-podophyllotoxin derivatives
摘要:
The synthesized nine aza-podophyllotoxin derivatives (8a-f, 10, 12 and 14) have been evaluated for their cytotoxicity in a panel of tumor cancer cell lines (Zr-75-1, MCF7, KB, Gurav, DWD, Colo-205, A-549 and Hop62). Among them, 8a and 8b compounds show stronger growth inhibition activity than the standard drug etoposide. Further, molecular docking simulations were carried out against human topoisomerase II, a putative target for these classes of molecules.
[EN] 4-AZA-2, 3-DIDEHYDROPODOPHYLLOTOXIN COMPOUNDS AND PROCESS FOR THE PREPARATION THEREOF<br/>[FR] COMPOSÉS DE 4-AZA-2, 3-DIDÉSHYDROPODOPHYLLOTOXINE ET PROCÉDÉS DE PRÉPARATION DE CEUX-CI
申请人:COUNCIL SCIENT IND RES
公开号:WO2012076942A1
公开(公告)日:2012-06-14
The present invention provides 4-Aza-2,3-didehydropodophyllotoxin compound of general formula A (4a- 4z and 4aa-4ae) as useful potential antitumour agents against human cancer cell lines. The present invention further provides a process for the synthesis of 4-Aza-2,3-didehydropodophyllotoxin compounds (4a-4z and 4aa-4ae).
4-AZA-2, 3-DIDEHYDROPODOPHYLLOTOXIN COMPOUNDS AND PROCESS FOR THE PREPARATION THEREOF
申请人:Ahmed Kamal
公开号:US20130245048A1
公开(公告)日:2013-09-19
The present invention provides 4-Aza-2,3-didehydropodophyllotoxin compound of general formula A (4a-4z and 4aa-4ae) as useful potential antitumour agents against human cancer cell lines. The present invention further provides a process for the synthesis of 4-Aza-2,3-didehydropodophyllotoxin compounds (4a-4z and 4aa-4ae).
US8927560B2
申请人:——
公开号:US8927560B2
公开(公告)日:2015-01-06
Synthesis, cytotoxic activity and docking studies of new 4-aza-podophyllotoxin derivatives
The synthesized nine aza-podophyllotoxin derivatives (8a-f, 10, 12 and 14) have been evaluated for their cytotoxicity in a panel of tumor cancer cell lines (Zr-75-1, MCF7, KB, Gurav, DWD, Colo-205, A-549 and Hop62). Among them, 8a and 8b compounds show stronger growth inhibition activity than the standard drug etoposide. Further, molecular docking simulations were carried out against human topoisomerase II, a putative target for these classes of molecules.